Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women

• Autor(a) principal: Benito-Garcia, F
• Data de Publicação: 2021
• Outros Autores: Pires, I, Lima, J
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10400.26/36620
• topic: Aspirina; Dessensibilização Imunológica; Síndrome Antifosfolipídica; Pre-Eclâmpsia; Gravidez; Desensitization, Immunologic; Antiphospholipid Syndrome; Pre-Eclampsia; Aspirin; Pregnancy

Low-dose acetylsalicylic acid (ASA) is widely used during pregnancy to prevent obstetric complications of placental dysfunction, such as preeclampsia, stillbirth and fetal growth restriction, and obstetric complications in pregnant women with antiphospholipid syndrome. ASA-sensitive pregnant women cannot benefit from the effects of ASA due to the possibility of severe or potentially life-threatening hypersensitivity reactions to ASA. ASA desensitization is a valuable and safe therapeutic option for these women, allowing them to start daily prophylaxis with ASA and prevent pregnancy complications. The authors discuss the recent advances in obstetric conditions preventable by ASA and the management of ASA hypersensitivity in pregnancy, including ASA desensitization. To encourage the implementation of ASA desensitization protocols in ASA-sensitive pregnant women, they also propose a practical approach for use in daily clinical practice.